CDMO News
Ritedose to Manufacture Verona Pharma’s Novel COPD Drug Ohtuvayre
The Ritedose Corporation has entered into a partnership with Verona Pharma plc to serve as the development and manufacturing partner for Ohtuvayre, a novel therapy for Chronic Obstructive Pulmonary Disease (COPD). This collaboration marks a significant advancement in COPD treatment,
18 September 2024
Stay ahead of trends and best practices
